What is Kebotix?
Kebotix specializes in accelerating the discovery of chemicals and materials via its proprietary AI platform. The company provides enterprise AI solutions specifically designed for materials discovery, empowering clients to expedite their product development cycles. At its core, Kebotix operates a self-driving lab that synergizes cloud technologies, machine learning, and automation to refine and optimize the research and development process. This innovative approach is particularly valuable for organizations aiming to enhance their materials science R&D capabilities and bring novel products to market more efficiently.
How much funding has Kebotix raised?
Kebotix has raised a total of $11.9M across 2 funding rounds:
Debt
$408K
Series A
$11.5M
Debt (2021): $408K with participation from PPP
Series A (2021): $11.5M led by Novo Holdings and SIT Capital
Key Investors in Kebotix
Novo Holdings
Novo Holdings, a Danish investment company wholly owned by the Novo Nordisk Foundation, focuses on life sciences and healthcare investments, suggesting a strategic interest in Kebotix's materials science applications.
SIT Capital
SIT Capital is an investment entity that has participated in Kebotix's funding rounds, indicating a belief in the company's technological advancements and market potential.
PPP
Public-Private Partnership
What's next for Kebotix?
The recent major enterprise-level funding positions Kebotix for significant expansion and further development of its AI-driven materials discovery platform. This strategic backing is expected to fuel advancements in their self-driving lab technology, enabling deeper integration of machine learning and automation. The company is poised to solidify its leadership in accelerating chemical and materials innovation, likely focusing on scaling its enterprise solutions to a broader client base and exploring new frontiers in materials science research and development.
See full Kebotix company page
